This inventor holds 2 USPTO granted patents, plus 4 CIPO patents and 1 EPO patent. Top assignees: Viventia Bio Inc., Viventia Biotechnologies Inc.. Active years: 2012-2017.
Company Filing History:
Years Active: 2012-2017
Title: Arjune Premsukh: Innovator in Antibody Research
Introduction
Arjune Premsukh is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody compositions and methods of use. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Premsukh's latest patents include "Anti-EPCAM antibodies and methods of use" and "Optimized nucleic acid sequences for the expression of VB4-845." The first patent focuses on compositions of antibodies and immunoconjugates that potentially lack T-cell epitopes, thereby eliciting a reduced immune response. This antibody may take various forms, including fragments and multimers, and is designed to bind to the epithelial cell adhesion molecule (EpCAM). The second patent discloses an optimized nucleic acid sequence encoding the immunoconjugate VB4-845, which includes modifications that enhance the yield of VB4-845 in expression systems.
Career Highlights
Throughout his career, Arjune Premsukh has worked with prominent companies in the biotechnology sector, including Viventia Biotechnologies Inc. and Viventia Bio Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in antibody development.
Collaborations
Premsukh has collaborated with notable colleagues such as Jeannick Cizeau and Glen MacDonald. These partnerships have further enriched his research and innovation efforts in the field.
Conclusion
Arjune Premsukh's work in antibody research exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations highlight his commitment to advancing medical science through effective solutions.